EAM
RETA

Erste Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Erste Asset Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-23,000
Closed -$2.32M – 593
2023
Q2 		$2.32M Hold
23,000
– – 0.04% 271
2023
Q1 		$2.07M Buy
+23,000
New +$1.35M 0.04% 284
2022
Q1 		– Sell
-6,700
Closed -$199K – 575
2021
Q4 		$172K Sell
6,700
-11,000
-62% -$851K ﹤0.01% 496
2021
Q3 		$1.86M Hold
17,700
– – 0.04% 281
2021
Q2 		$2.6M Hold
17,700
– – 0.05% 263
2021
Q1 		$1.72M Hold
17,700
– – 0.04% 290
2020
Q4 		$2.3M Sell
17,700
-4,900
-22% -$644K 0.06% 249
2020
Q3 		$2.14M Hold
22,600
– – 0.07% 238
2020
Q2 		$3.48M Hold
22,600
– – 0.14% 165
2020
Q1 		$3.66M Hold
22,600
– – 0.21% 124
2019
Q4 		$4.78M Hold
22,600
– – 0.21% 117
2019
Q3 		$1.9M Hold
22,600
– – 0.1% 191
2019
Q2 		$2.07M Buy
+22,600
New +$1.95M 0.11% 170

Other funds holding RETA

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Erste Asset Management's RETA Position: Q3 2023 in Review

Erste Asset Management sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 23,000 shares — an estimated $2.32M sold.

Erste Asset Management first reported a position in RETA in Q2 2019 and held it in 13 quarters. The position peaked at $4.78M in Q4 2019. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

  • Erste Asset Management reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Erste Asset Management sold 23,000 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $2.32M.
  • Erste Asset Management first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2019 and held it in 13 quarters.
  • Erste Asset Management's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $4.78M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Erste Asset Management's 13F filing for Q3 2023, filed 26 Nov 2024.